New inhaler propellant tested for lung safety in healthy volunteers
NCT ID NCT06506266
First seen Apr 20, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study tested whether a new propellant (HFA-152a) used in inhalers affects the lungs' ability to clear mucus, compared to a standard propellant (HFA-134a). Twenty-four healthy adults inhaled each propellant and then breathed in a harmless radioactive tracer to measure lung clearance. The goal was to check safety, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.